isomethyleugenol has been researched along with tamoxifen in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (13.79) | 18.7374 |
1990's | 6 (20.69) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 7 (24.14) | 2.80 |
Authors | Studies |
---|---|
Beaune, P; Berthou, F; Dreano, Y; Jacolot, F; Riche, C; Simon, I | 1 |
Davidson, NE; Gelmann, EP; Kasid, A; Lippman, ME | 1 |
Chambon, P; Kumar, V | 1 |
Glenn, EM; Ludens, JH; Rohloff, NA; Skulnick, HI; Smith, RJ; Wendling, MG; Wierenga, W | 1 |
Eppenberger, U; Löser, R; Seibel, K | 1 |
Davies, AM; Jones, RM; Lim, CK; Martin, EA; Smith, LL; White, IN | 1 |
Dwivedy, I; Katzenellenbogen, JA; O'Neil, JP; Ray, S; Tandon, A; Wilson, SR | 1 |
Hemminki, K; Mäntylä, E; Rajaniemi, H | 1 |
Cattaneo, M | 1 |
Carmichael, PL; Cole, KJ; Davis, W; Hewer, A; Horton, MN; Osborne, MR; Phillips, DH | 1 |
Ho, SM; LaSpina, M; Lau, KM; Long, J | 1 |
Boek-Dohalská, L; Hodek, P; Stiborová, M; Sulc, M | 1 |
Agouridas, V; Blazejewski, JC; Cleeren, A; Kizilian, E; Laïos, I; Leclercq, G; Magnier, E | 1 |
Chen, T; Fang, Q; Kadam, S; Labow, M; Lei, H; Lewis, T; Li, E; Lohmann, F; Loureiro, J; Su, H; Yang, Y | 1 |
Flockhart, DA; Huang, TH; Huang, Y; Li, L; Liu, Y; Nephew, KP; Shen, C; Skaar, TC; Teng, M; Wang, G; Wang, Y; Wang, Z; Yan, P; Zhao, Y | 1 |
He, J; Nguyen, AT; Taranova, O; Zhang, Y | 1 |
Kang, KW; Kim, SK; Kwak, HC; Lee, JY; Oh, SJ; Phuong, NT; Ryu, CS | 1 |
Csabai, K; Fenyvesi, É; Malanga, M; Szemán, J; Szente, L | 1 |
Lawrence, HR; Lawrence, NJ; Mahajan, K; Mahajan, NP | 1 |
He, W; Liu, R; Yang, SH; Yuan, F | 1 |
Floer, M; Gjidoda, A; McAndrew, MJ; Tagore, M | 1 |
Agger, K; Helin, K; Johansen, JV; Kooistra, SM; Miyagi, S; Pedersen, MT | 1 |
Kim, SS; Lee, MH; Lee, MO | 1 |
Chan, YC; Chen, DR; Chen, Y; Hsu, KW; Liu, YE; Wang, YF; Wu, HT | 1 |
Bade, D; Dai, X; Gonzalez, G; Huang, M; Li, L; Liu, X; Miao, W; Sun, Y; Wang, Y; Yuan, J | 1 |
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P | 1 |
Emami Razavi, A; Jahangiri, R; Jamialahmadi, K; Mosaffa, F; Teimoori-Toolabi, L | 1 |
Hamada, Y; Inada, E; Iseki, M; Katsuda, Y; Kondo, T; Kuzumaki, N; Matsufuji, M; Mori, T; Narita, M; Sato, D; Takeshima, H; Tanaka, K; Ushijima, T; Yamabe, Y; Yamaguchi, K | 1 |
Hu, C; Hu, M; Li, Z; Ma, S; Wang, M; Xiao, W; Yang, B; Zhou, M; Zhou, Q | 1 |
1 review(s) available for isomethyleugenol and tamoxifen
Article | Year |
---|---|
Hyperhomocysteinemia, atherosclerosis and thrombosis.
Topics: Adult; Aged; Animals; Arteriosclerosis; Avitaminosis; Case-Control Studies; Clinical Trials as Topic; Cohort Studies; Cross-Sectional Studies; Cystathionine beta-Synthase; Female; Folic Acid; Gene Frequency; Homocysteine; Homocystinuria; Hormone Replacement Therapy; Humans; Hyperhomocysteinemia; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Muscle, Smooth, Vascular; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Primates; Prospective Studies; Pyridoxine; Risk Factors; Smoking; Tamoxifen; Thrombophilia; Thrombosis; Vitamin B 12 | 1999 |
28 other study(ies) available for isomethyleugenol and tamoxifen
Article | Year |
---|---|
Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.
Topics: Animals; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Immunoblotting; Kinetics; Methylation; Microsomes, Liver; Oxidoreductases, N-Demethylating; Oxygenases; Rabbits; Tamoxifen; Testosterone | 1991 |
Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells.
Topics: Amanitins; Breast Neoplasms; Cell Cycle; Cell Line; DNA; Estradiol; Estrogen Antagonists; Estrogens; Gene Expression Regulation; Humans; Methylation; Pyrrolidines; RNA; RNA, Messenger; Tamoxifen; Thiophenes; Thymidine; Thymidine Kinase; Time Factors | 1986 |
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.
Topics: Binding Sites; Cell Line; Chromosome Deletion; DNA; DNA Probes; Estradiol; Humans; Ligands; Macromolecular Substances; Methylation; Receptors, Estrogen; Tamoxifen | 1988 |
Pyrimidinones. 3. N-substituted 6-phenylpyrimidinones and pyrimidinediones with diuretic/hypotensive and antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Arthritis; Diuresis; Dose-Response Relationship, Drug; Female; Furosemide; Guanethidine; Heart; Hydrochlorothiazide; Hypotension; Male; Methylation; Natriuresis; Phenylacetates; Potassium; Pyrimidinones; Rats; Rats, Inbred Strains; Stilbenes; Structure-Activity Relationship; Tamoxifen | 1986 |
No loss of estrogenic or anti-estrogenic activity after demethylation of droloxifene (3-OH-tamoxifen).
Topics: Animals; Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line; Estrogen Antagonists; Female; Humans; Methylation; Rats; Receptors, Estrogen; Tamoxifen; Uterus | 1985 |
Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts.
Topics: Animals; Biotransformation; Cattle; DNA Adducts; DNA Damage; Horseradish Peroxidase; Methylation; Protein Binding; Serum Albumin, Bovine; Tamoxifen; Toremifene | 1995 |
An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman.
Topics: Centchroman; Crystallization; Crystallography, X-Ray; Estradiol; Iodides; Methylation; Molecular Conformation; Molecular Structure; Nafoxidine; Receptors, Estrogen; Stereoisomerism; Tamoxifen | 1994 |
DNA adduct formation by tamoxifen and structurally-related compounds in rat liver.
Topics: Animals; Anticarcinogenic Agents; Chromatography, High Pressure Liquid; DNA; DNA Adducts; Female; Liver; Methylation; Phosphates; Rats; Rats, Sprague-Dawley; Tamoxifen | 1998 |
N-demethylation accompanies alpha-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
Topics: Animals; Biotransformation; Cells, Cultured; Chromatography, High Pressure Liquid; DNA; DNA Adducts; Female; Hydroxylation; Liver; Methylation; Oxidation-Reduction; Phosphorus Radioisotopes; Rats; Rats, Inbred F344; Tamoxifen | 1999 |
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Topics: Cell Culture Techniques; Cell Division; Cells, Cultured; Diethylstilbestrol; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Fulvestrant; Humans; Male; Methylation; Oligonucleotides, Antisense; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteins; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |
alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Estradiol; Hydroxylation; Male; Methylation; Microsomes, Liver; Rabbits; Recombinant Proteins; Tamoxifen | 2001 |
Loss of antagonistic activity of tamoxifen by replacement of one N-methyl of its side chain by fluorinated residues.
Topics: Cell Line, Tumor; Cell Proliferation; Estrogen Antagonists; Fluorine; Humans; Methylation; Molecular Structure; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Transcription Factor AP-1; Transcription, Genetic | 2006 |
KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chromatin Immunoprecipitation; Embryonic Stem Cells; Histone-Lysine N-Methyltransferase; Histones; Immunoblotting; Methylation; Mice; Oligonucleotide Array Sequence Analysis; Protein Methyltransferases; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen | 2010 |
A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.
Topics: Bayes Theorem; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Epigenesis, Genetic; Estrogen Receptor alpha; Gene Regulatory Networks; Genomics; Histones; Humans; Lysine; Methylation; Models, Genetic; Reproducibility of Results; RNA Polymerase II; Tamoxifen; Time Factors | 2011 |
Essential role of DOT1L in maintaining normal adult hematopoiesis.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Estrogen Antagonists; Hematopoiesis; Histone-Lysine N-Methyltransferase; Histones; Methylation; Methyltransferases; Mice; Mice, Knockout; Recombination, Genetic; Tamoxifen | 2011 |
Elevation of cysteine consumption in tamoxifen-resistant MCF-7 cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Glutathione; Humans; Membrane Transport Modulators; Methionine; Methylation; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; S-Adenosylhomocysteine; S-Adenosylmethionine; Tamoxifen; Taurine; Up-Regulation | 2013 |
Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power.
Topics: Amiodarone; beta-Cyclodextrins; Cholesterol; Chromatography, High Pressure Liquid; Fatty Acids; Furosemide; Isomerism; Magnetic Resonance Spectroscopy; Methylation; Solubility; Tamoxifen | 2014 |
ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Jumonji Domain-Containing Histone Demethylases; Luciferases; Mammary Glands, Human; Methylation; Models, Molecular; Molecular Sequence Data; Neuregulin-1; Protein Binding; Protein-Tyrosine Kinases; Pyrimidines; Receptor, ErbB-2; Signal Transduction; Tamoxifen; Thiazoles; Transcription, Genetic | 2014 |
Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Electron Transport Complex I; Glioma; Humans; Male; Methylation; Mitochondria; Promoter Regions, Genetic; Rats, Sprague-Dawley; Tamoxifen; Temozolomide; Tumor Suppressor Proteins | 2015 |
The Lineage-Specific Transcription Factor PU.1 Prevents Polycomb-Mediated Heterochromatin Formation at Macrophage-Specific Genes.
Topics: Animals; Cell Differentiation; Cell Line; Female; Heterochromatin; Histones; Interleukin-12 Subunit p40; Interleukin-1alpha; Lipopolysaccharides; Macrophages; Methylation; Mice; Mice, Inbred BALB C; Nucleosomes; Pluripotent Stem Cells; Polycomb Repressive Complex 2; Protein Binding; Proto-Oncogene Proteins; Receptors, Estrogen; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Tamoxifen; Trans-Activators; Transcription, Genetic | 2015 |
Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Interleukin-3 Receptor alpha Subunit; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Methylation; Mice; Mice, Knockout; Protein Binding; Tamoxifen | 2016 |
Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Methyltransferases; Humans; Methylation; RNA, Small Interfering; Tamoxifen | 2020 |
MLL3 Induced by Luteolin Causes Apoptosis in Tamoxifen-Resistant Breast Cancer Cells through H3K4 Monomethylation and Suppression of the PI3K/AKT/mTOR Pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Luteolin; Methylation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; ras Proteins; Signal Transduction; Tamoxifen; TOR Serine-Threonine Kinases | 2020 |
Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m
Topics: Adenosine; Adenylate Kinase; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; MCF-7 Cells; Methylation; Methyltransferases; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tamoxifen; Transfection | 2020 |
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen | 2021 |
Topics: Breast Neoplasms; DNA Methylation; Drug Resistance, Neoplasm; Female; Humans; Methylation; Neoplasm Recurrence, Local; Nuclear Receptor Coactivator 3; PAX2 Transcription Factor; Promoter Regions, Genetic; Tamoxifen | 2022 |
Histone modification of pain-related gene expression in spinal cord neurons under a persistent postsurgical pain-like state by electrocautery.
Topics: Animals; Annexins; Benzazepines; Cornified Envelope Proline-Rich Proteins; Disease Models, Animal; Electrocoagulation; Female; Foot Injuries; Gene Expression Regulation; Gene Knock-In Techniques; Genes, fos; Genes, Reporter; Histone Code; Histones; Hyperalgesia; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuralgia; Neurons; Pain, Postoperative; Pyrimidines; RNA, Messenger; Spinal Cord; Tamoxifen | 2021 |
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estrogens; Female; Genistein; Histones; Humans; Interleukin-6; Interleukin-8; Methylation; Receptor, ErbB-2; Tamoxifen | 2023 |